BERGEN
Norway
9
2018-02-01
8
2019-07-02
These are the the leading inventors for applications assigned to BerGenBio AS:
BerGenBio AS based in BERGEN, NO has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Pharmaceutically active compounds
#2 | 2017-12-07 ✅ Patent 10,208,121 granted on 2019-02-19Anti-Axl antagonistic antibodies
#3 | 2017-11-23 ✅ Patent 9,994,553 granted on 2018-06-12Process for the purification of the Axl tyrosine receptor kinase inhibitor “R428”
#4 | 2017-11-02SLFN11 AS BIOMARKER FOR AML
#5 | 2017-05-11 ✅ Patent 9,975,954 granted on 2018-05-22Anti-Axl antibodies
#6 | 2017-04-20 ✅ Patent 9,975,953 granted on 2018-05-22Anti-Axl antibodies
#7 | 2016-11-24 ✅ Patent 9,801,880 granted on 2017-10-31Use of kinase inhibitors
#8 | 2014-07-10 ✅ Patent 9,783,801 granted on 2017-10-10Methods for creating and identifying functional RNA interference elements
#9 | 2011-01-13 ✅ Patent 8,735,064 granted on 2014-05-27Methods for creating and identifying functional RNA interference elements
Also check out BerGenBio AS's (Bergen, Norway) applicant profile with 2 patent applications submitted.
71002 ⎘